Changes in the management of acne: 2009-2019 - 14/04/20
Key words : acne, antibiotic resistance, guidelines
Le texte complet de cet article est disponible en PDF.
Funding sources: None. |
|
Disclosure: Dr Thiboutot is an investigator and consultant to Botanix, Cassiopea, and Novartis; an investigator for Foamix; and a consultant to Dermira, Galderma, Novan, and Sebacia. Dr Dreno is an advisory board member and speaker for Galderma, Meda, and Fabre. Dr Rueda is an employee of Eli Lilly company and a former employee of Galderma LP. Dr Gollnick is an advisory board member for Galderma, Meda, and Mylan. Ms Sanders has no conflicts of interest to disclose. |
|
Reprints not available from the authors. |
Vol 82 - N° 5
P. 1268-1269 - mai 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?